Edition:
India

TSO3 Inc (TOS.TO)

TOS.TO on Toronto Stock Exchange

2.53CAD
--
Change (% chg)

-- (--)
Prev Close
$2.53
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
178,094
52-wk High
$3.36
52-wk Low
$2.05

Latest Key Developments (Source: Significant Developments)

TSO3 provides duodenoscope regulatory filing update
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - TSO3 Inc :TSO3 provides duodenoscope regulatory filing update.TSO3-Responded to request for additional information from U.S. FDA; information is in support of submission to extend claims of Sterizone VP4 sterilizer​.  Full Article

TSO3 reports record third quarter 2017 results
Tuesday, 7 Nov 2017 

Nov 6 (Reuters) - TSO3 Inc :TSO3 reports record third quarter 2017 results.TSO3 Inc-qtrly ‍revenue increased to $5.1 million, an 11% sequential increase over $4.6 million recorded in Q2 of 2017​.Qtrly loss per share $0.02‍​.  Full Article

TSO3 reports Q2 loss per share $0.02
Wednesday, 3 Aug 2016 

TSO3 Inc : Q2 loss per share $0.02 .Revenues were $3.0 million in Q2 2016 versus $3.1 million in Q1 2016 and $0.1 million in Q2 2015..  Full Article

TSO3 responds to U.S. FDA on extended claims, gives operations update
Thursday, 2 Jun 2016 

Tso3 Inc : TSO3 responds to u.s. Regulators on extended claims and provides operations update . Responded to a previously announced request for additional information by U.S. Food and Drug Administration . Co's response allows FDA to continue their review for market clearance on extended claims for sterizone VP4 sterilizer in U.S. . Production and operational improvements co made on assembly facility had a minimal impact on Q2 2016 production . Substantially completed its improvements to its manufacturing facility in Québec .Operational improvements to its assembly facility are designed to increase assembly capacity and efficiency.  Full Article

BRIEF-TSO3 provides duodenoscope regulatory filing update

* TSO3-Responded to request for additional information from U.S. FDA; information is in support of submission to extend claims of Sterizone VP4 sterilizer​ Source text for Eikon: Further company coverage: